ZC3H12C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.47059999955346E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.71279999960916E-07 |
Normal-vs-Stage2 |
1.266250E-02 |
Normal-vs-Stage3 |
3.18040000002462E-06 |
Normal-vs-Stage4 |
1.620330E-04 |
Stage1-vs-Stage2 |
1.573200E-01 |
Stage1-vs-Stage3 |
7.959800E-01 |
Stage1-vs-Stage4 |
5.705600E-01 |
Stage2-vs-Stage3 |
1.053430E-01 |
Stage2-vs-Stage4 |
1.127220E-01 |
Stage3-vs-Stage4 |
6.434800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.06239955405863E-10 |
Normal-vs-AfricanAmerican |
1.200370E-03 |
Normal-vs-Asian |
4.752400E-04 |
Caucasian-vs-AfricanAmerican |
1.700410E-01 |
Caucasian-vs-Asian |
4.306200E-01 |
AfricanAmerican-vs-Asian |
6.198000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.27535825923087E-12 |
Normal-vs-Female |
3.480200E-03 |
Male-vs-Female |
8.324700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.456400E-03 |
Normal-vs-Extreme_Weight |
1.62647673107585E-12 |
Normal-vs-Obese |
4.33560000000499E-05 |
Normal-vs-Extreme_Obese |
2.419700E-04 |
Normal_Weight-vs-Extreme_Weight |
2.450000E-02 |
Normal_Weight-vs-Obese |
6.773800E-01 |
Normal_Weight-vs-Extreme_Obese |
2.392600E-01 |
Extreme_Weight-vs-Obese |
1.140930E-03 |
Extreme_Weight-vs-Extreme_Obese |
3.722600E-01 |
Obese-vs-Extreme_Obese |
3.701200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.331700E-02 |
Normal-vs-Age(41-60Yrs) |
7.62470000000848E-05 |
Normal-vs-Age(61-80Yrs) |
5.65239965943931E-10 |
Normal-vs-Age(81-100Yrs) |
8.428900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.889800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.138300E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.983400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.055700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.465400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.216800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.69420033557799E-12 |
Normal-VS-Type2 PRCC |
1.635410E-03 |
Normal-VS-KIRP CIMP |
3.996000E-01 |
Normal-VS-Unclassified PRCC |
4.183000E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.730400E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.074600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.111770E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.810600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.854400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.431600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.25059999922917E-08 |
Normal-vs-N1 |
7.395300E-04 |
Normal-vs-N2 |
1.237940E-03 |
N0-vs-N1 |
2.244000E-01 |
N0-vs-N2 |
3.247800E-01 |
N1-vs-N2 |
1.614160E-01 |
|
|